Journal of Allergy and Clinical Immunology, Journal Year: 2023, Volume and Issue: 152(3), P. 567 - 581
Published: May 27, 2023
Language: Английский
Journal of Allergy and Clinical Immunology, Journal Year: 2023, Volume and Issue: 152(3), P. 567 - 581
Published: May 27, 2023
Language: Английский
Nature, Journal Year: 2022, Volume and Issue: 611(7934), P. 139 - 147
Published: Aug. 31, 2022
Abstract Severe SARS-CoV-2 infection 1 has been associated with highly inflammatory immune activation since the earliest days of COVID-19 pandemic 2–5 . More recently, these responses have emergence self-reactive antibodies pathologic potential 6–10 , although their origins and resolution remained unclear 11 Previously, we others identified extrafollicular B cell activation, a pathway formation new autoreactive in chronic autoimmunity 12,13 as dominant feature severe critical (refs. 14–18 ). Here, using single-cell repertoire analysis patients mild disease, identify expansion naive-derived, low-mutation IgG1 population antibody-secreting cells (ASCs) reflecting features low selective pressure. These correlate progressive, broad, clinically relevant autoreactivity, particularly directed against nuclear antigens carbamylated proteins, emerging 10–15 after onset symptoms. Detailed low-selection compartment shows high frequency clonotypes specific for both autoantigens, including pathogenic autoantibodies glomerular basement membrane. We further contraction this on recovery, re-establishment tolerance standards concomitant loss acute-derived ASCs irrespective antigen specificity. However, serological autoreactivity persists subset postacute sequelae, raising important questions to contribution continuing symptomology recovery. In summary, study demonstrates origins, breadth COVID-19, implications early intervention treatment post-COVID sequelae.
Language: Английский
Citations
119JAMA Network Open, Journal Year: 2022, Volume and Issue: 5(3), P. e221313 - e221313
Published: March 9, 2022
Language: Английский
Citations
85Frontiers in Immunology, Journal Year: 2022, Volume and Issue: 13
Published: June 10, 2022
Several COVID-19 convalescents suffer from the post-acute COVID-syndrome (PACS)/long COVID, with symptoms that include fatigue, dyspnea, pulmonary fibrosis, cognitive dysfunctions or even stroke. Given scale of worldwide infections, long-term recovery and integrative health-care in nearest future, it is critical to understand cellular molecular mechanisms as well possible predictors longitudinal post-COVID-19 responses convalescent individuals. The immune system T cell alterations are proposed drivers COVID syndrome. However, despite number studies on COVID-19, many them addressed only severe short-term responses. Here, we performed mild, moderate COVID-19-convalescent patients, at two time points (3 6 months infection), assess dynamics cells landscape, integrated patients-reported symptoms. We show among subsets exhibit different, severity- time-dependent dynamics, result a polarization towards an exhausted/senescent state CD4+ CD8+ perturbances Tregs. In particular, high proportion CD57+ terminal effector cells, together significant decrease naïve population, augmented granzyme B IFN-γ production unresolved inflammation after infection. Mild showed increased naïve, decreased central memory Treg subsets. Patients all severity groups can be predisposed long symptoms, fatigue not necessarily related dysfunctions, was found convalescents. conclusion, functional remodeling could seen two-step process, leading distinct states Our data imply attenuation blocking might influence post-COVID either search for any treatment prevent PACS further complications mandatory patients SARS-CoV-2 infection, those suffering COVID-19.
Language: Английский
Citations
83Immunology Letters, Journal Year: 2023, Volume and Issue: 255, P. 67 - 76
Published: March 1, 2023
Language: Английский
Citations
45Cellular and Molecular Immunology, Journal Year: 2024, Volume and Issue: 21(2), P. 119 - 133
Published: Jan. 18, 2024
The COVID-19 pandemic, which was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a worldwide health crisis due to its transmissibility. SARS-CoV-2 infection results in illness and can lead significant complications affected individuals. These encompass symptoms such as coughing, distress, fever, infectious shock, distress (ARDS), even multiple-organ failure. Animal models serve crucial tools for investigating pathogenic mechanisms, immune responses, escape antiviral drug development, vaccines against SARS-CoV-2. Currently, various animal infection, nonhuman primates (NHPs), ferrets, hamsters, many different mouse models, have been developed. Each model possesses distinctive features applications. In this review, we elucidate the response elicited patients provide an overview of characteristics mainly used well corresponding responses applications these models. A comparative analysis transcriptomic alterations lungs from revealed that K18-hACE2 mouse-adapted virus exhibited highest similarity with deceased patients. Finally, highlighted current gaps related research between studies clinical investigations, underscoring lingering scientific questions demand further clarification.
Language: Английский
Citations
17Journal of Clinical Immunology, Journal Year: 2021, Volume and Issue: 41(8), P. 1709 - 1722
Published: Oct. 20, 2021
Abstract Background Data on immune responses to SARS-CoV-2 in patients with Primary Antibody Deficiencies (PAD) are limited infected and heterogeneous cohorts after immunization. Methods Forty-one Common Variable Immune (CVID), six X-linked Agammaglobulinemia (XLA), 28 healthy age-matched controls (HD) were analyzed for anti-Spike anti-receptor binding domain (RBD) antibody production, generation of Spike-specific memory B-cells, T-cells before vaccination one week the second dose BNT162b2 vaccine. Results The vaccine induced IgG IgA all HD 20% naive CVID patients. Anti-Spike detectable 4 out 7 previously boosted seven by subsequent immunization raising higher levels than naïve infection. While generated RBD-specific atypical while B-cells undetectable patients, indicating incapability generate this new specificity. Specific T-cell evident defective 30% CVID. All but patient XLA responded specific only. Conclusion In PAD early occurred, possibly extra-follicular or incomplete germinal center reactions. If these might result a partial protection from infection reinfection is now unknown. Our data suggests that more effectively primes response alone, suggesting need third not infected.
Language: Английский
Citations
79Frontiers in Immunology, Journal Year: 2021, Volume and Issue: 12
Published: Oct. 5, 2021
Aging is considered to be an important risk factor for several inflammatory diseases. B cells play a major role in chronic diseases by antibody secretion, antigen presentation and T cell regulation. Different subsets have been implicated infections multiple autoimmune Since aging decreases numbers, affects impairs responses, the aged expected impacts on development progression of these In this review, we summarize health disease settings, such as atherosclerotic disease. Furthermore, provide overview age-related changes function with respect their impact
Language: Английский
Citations
68Frontiers in Immunology, Journal Year: 2023, Volume and Issue: 14
Published: Jan. 30, 2023
The current coronavirus pandemic (COVID-19), caused by SARS-CoV-2, has had devastating effects on the global health and economic system. cellular molecular mediators of both innate adaptive immune systems are critical in controlling SARS-CoV-2 infections. However, dysregulated inflammatory responses imbalanced immunity may contribute to tissue destruction pathogenesis disease. Important mechanisms severe forms COVID-19 include overproduction cytokines, impairment type I IFN response, overactivation neutrophils macrophages, decreased frequencies DC cells, NK cells ILCs, complement activation, lymphopenia, Th1 Treg hypoactivation, Th2 Th17 hyperactivation, as well clonal diversity B lymphocyte function. Given relationship between disease severity an system, scientists have been led manipulate system a therapeutic approach. For example, anti-cytokine, cell, IVIG therapies received attention treatment COVID-19. In this review, role development progression is discussed, focusing aspects mild vs. Moreover, some immune- based approaches being investigated. Understanding key processes involved developing agents optimizing related strategies.
Language: Английский
Citations
41Vaccines, Journal Year: 2023, Volume and Issue: 11(2), P. 408 - 408
Published: Feb. 10, 2023
The coronavirus 2019 (COVID-19) pandemic was caused by a positive sense single-stranded RNA (ssRNA) severe acute respiratory syndrome 2 (SARS-CoV-2). However, other human coronaviruses (hCoVs) exist. Historical pandemics include smallpox and influenza, with efficacious therapeutics utilized to reduce overall disease burden through effectively targeting competent host immune system response. is composed of primary/secondary lymphoid structures initially eight types cell types, many subtypes, traversing membranes utilizing signaling cascades that contribute towards clearance pathogenic proteins. Other proteins discussed cluster differentiation (CD) markers, major histocompatibility complexes (MHC), pleiotropic interleukins (IL), chemokines (CXC). historical concepts immunity are the innate adaptive systems. represented T cells, B antibodies. macrophages, neutrophils, dendritic complement system. viruses can affect regulate cycle progression for example, in cancers papillomavirus (HPV: cervical carcinoma), Epstein-Barr virus (EBV: lymphoma), Hepatitis C (HB/HC: hepatocellular carcinoma) Leukemia Virus-1 (T leukemia). Bacterial infections also increase risk developing cancer (e.g.,
Language: Английский
Citations
37EMBO Molecular Medicine, Journal Year: 2023, Volume and Issue: 15(9)
Published: June 5, 2023
Abstract Most mature B cells can be divided into four subtypes based on the expression of surface markers IgD and CD27: + CD27 − naïve cells, unswitched memory switched double‐negative (DN) cells. Despite their small population size in normal peripheral blood, DN play integral roles various diseases. For example, they generate autoimmunity autoimmune conditions, while these may both antipathogenic responses COVID‐19, or act a purely capacity malaria. Recently, have been identified nasopharyngeal carcinoma non‐small‐cell lung cancers, where an immunosuppressive role. The distinct functions that different diseases suggest are heterogeneous B‐cell population. Therefore, further study mechanisms underlying involvement is essential for understanding pathogenesis development therapeutic strategies. Further research thus warranted to characterize detail.
Language: Английский
Citations
37